Cannabis Testing Services Market, by Test Type (Potency Testing, Terpene Profiling, Cannabinoid Profiling [CBD Testing and THC Testing], Pesticide Screening, Residual Solvent Testing, Microbiological Screening, and Other Tests), by Product Type (Instruments [Chromatography Instruments {Liquid Chromatography, Gas Chromatography, and Others}, Spectroscopy Instruments {Mass Spectroscopy and Atomic Spectroscopy}, Other Instruments], and Consumables & Test Kits), by End Users (Testing Laboratories, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Cannabis, often known as marijuana, is a psychoactive substance derived from the cannabis plant. The major psychoactive component of cannabis is tetrahydrocannabinol (THC). Cannabis can be consumed via smoking, vaporizing, ingesting, or consuming it as an extract. Over the past decade, development of therapies derived from cannabis and its components is increasing. Medical marijuana has been studied to treat various medical conditions including cancer, multiple sclerosis, post-traumatic stress disorder, anxiety, among others. Furthermore, the U.S. FDA offers an active program assisting drug developers to investigate marijuana or its components through properly controlled clinical trials, and to demonstrate the potential for safe and effective uses. Cannabis has been beneficial in a variety of medicinal uses, including decreasing chemotherapy-induced nausea, increasing hunger in Acquired Immunodeficiency Syndrome (AIDS) patients, regulating muscle spasms in multiple sclerosis patients, and so forth. Cannabis testing is the analytical study of cannabis to determine its safety before it is consumed by humans. Cannabinoids have a variety of impacts on the body and is used for medicinal purposes. Marijuana testing is usually done on a urine sample, although it can also be done on blood, saliva, or hair.
Market Dynamics
Increasing adoption of inorganic growth strategies such as acquisition by key players is expected to drive the market growth over the forecast period. For instance, in December 2021, Pfizer Inc., multinational pharmaceutical and Biotechnology Corporation had acquired with the clinical-stage company Arena Pharmaceuticals, a Biotech Company. The fundamental of its cannabis operation consists of Olorinab (APD371), an investigational, oral, full agonist of the cannabinoid type 2 receptor (CB2), which aims to treat patients with diseases affecting the stomach and intestine. Furthermore, Pfizer Inc., an American multinational pharmaceutical and biotechnology corporation had signed agreement for testing analysis with the clinical-stage company Arena Pharmaceuticals for a total equity value of around $6.7 billion.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook